Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Effect of Milk Components on the Response to the Pneumonia Vaccine in Senior Citizens

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of California, Davis
ClinicalTrials.gov Identifier:
NCT01626300
First received: June 20, 2012
Last updated: June 21, 2012
Last verified: June 2012
  Purpose

The purpose of this study is to determine if the daily use of a certain amount and type of milk component for 2 months provides a significant stimulation to the immune system and specifically increases the chances of being protected against pneumonia after the vaccination.


Condition
To Evaluate the Effects of Milk Components (Whey and/or Inulin)
on the Response to Pneumococcal Vaccines in the Elderly.

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: The Effect of Milk Components on the Response to the Pneumonia Vaccine in Senior Citizens: A Randomized Placebo-controlled Clinical Trial

Resource links provided by NLM:


Further study details as provided by University of California, Davis:

Enrollment: 45
Study Start Date: December 2007
Study Completion Date: June 2008
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   60 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Healthy subjects > 60 years of age.

Criteria

Inclusion Criteria:

  • Age and a willingness to participate

Exclusion Criteria:

  • • Smoking history within 10 years

    • Underlying neoplasia or immunological disease
    • Use of oral cortisone or other immunosuppressive agents
    • Current consumption of milk and milk products greater than 1 unit of milk, 1 yogurt, or 1 serving of fresh cheese a day.
    • Food faddists or those taking a non-traditional diet
    • Current consumption of dietary supplements
    • People with a known history of milk allergy
    • People with chronic renal failure
    • People with chronic inflammatory diseases taking daily doses of NSAIDs for longer than 4 weeks at the time of enrollment.
    • Previous administration of the pneumomax vaccine
    • Reduced physical activity (i.e. NYHA classes III-IV)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: University of California, Davis
ClinicalTrials.gov Identifier: NCT01626300     History of Changes
Other Study ID Numbers: 200513884-2
Study First Received: June 20, 2012
Last Updated: June 21, 2012
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on November 20, 2014